Cannabis Watch: Jefferies issues bullish note on buy-rated OrganiGram, upgrades Cronos and Hexo and cuts Tilray’s price target

This article was originally published on MarketWatch

Jefferies upgraded two Canadian cannabis stocks on Thursday and reduced his price target on a third, remaining most bullish on buy-rated OrganiGram Holdings Inc., which it said is “really starting to hit its stride.”